160 related articles for article (PubMed ID: 21035854)
1. CDDO-Im is a stimulator of megakaryocytic differentiation.
Petronelli A; Pelosi E; Santoro S; Saulle E; Cerio AM; Mariani G; Labbaye C; Testa U
Leuk Res; 2011 Apr; 35(4):534-44. PubMed ID: 21035854
[TBL] [Abstract][Full Text] [Related]
2. CDDO-Im, an antitumor molecule that also improves platetet production.
Sardina JL; López-Ruano G; Sánchez-Sánchez B; Hernández-Hernández A
Leuk Res; 2011 Apr; 35(4):427-8. PubMed ID: 21074266
[No Abstract] [Full Text] [Related]
3. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
[TBL] [Abstract][Full Text] [Related]
4. In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.
Saulle E; Riccioni R; Pelosi E; Stafness M; Mariani G; De Tuglie G; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 36(1):59-76. PubMed ID: 16360329
[TBL] [Abstract][Full Text] [Related]
5. The novel synthetic triterpenoid, CDDO-imidazolide, inhibits inflammatory response and tumor growth in vivo.
Place AE; Suh N; Williams CR; Risingsong R; Honda T; Honda Y; Gribble GW; Leesnitzer LM; Stimmel JB; Willson TM; Rosen E; Sporn MB
Clin Cancer Res; 2003 Jul; 9(7):2798-806. PubMed ID: 12855660
[TBL] [Abstract][Full Text] [Related]
6. Enforced expression of KDR receptor promotes proliferation, survival and megakaryocytic differentiation of TF1 progenitor cell line.
Coppola S; Narciso L; Feccia T; Bonci D; Calabrò L; Morsilli O; Gabbianelli M; De Maria R; Testa U; Peschle C
Cell Death Differ; 2006 Jan; 13(1):61-74. PubMed ID: 15962006
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid triggers erythro/megakaryocyte lineage decision through induction of GFI1B and MLLT3 expression.
Zini R; Norfo R; Ferrari F; Bianchi E; Salati S; Pennucci V; Sacchi G; Carboni C; Ceccherelli GB; Tagliafico E; Ferrari S; Manfredini R;
Exp Hematol; 2012 Dec; 40(12):1043-1054.e6. PubMed ID: 22885124
[TBL] [Abstract][Full Text] [Related]
8. High sensitivity of ovarian cancer cells to the synthetic triterpenoid CDDO-Imidazolide.
Petronelli A; Saulle E; Pasquini L; Petrucci E; Mariani G; Biffoni M; Ferretti G; Scambia G; Benedetti-Panici P; Greggi S; Cognetti F; Russo MA; Sporn M; Testa U
Cancer Lett; 2009 Sep; 282(2):214-28. PubMed ID: 19364626
[TBL] [Abstract][Full Text] [Related]
9. Enforced TAL-1 expression stimulates primitive, erythroid and megakaryocytic progenitors but blocks the granulopoietic differentiation program.
Valtieri M; Tocci A; Gabbianelli M; Luchetti L; Masella B; Vitelli L; Botta R; Testa U; Condorelli GL; Peschle C
Cancer Res; 1998 Feb; 58(3):562-9. PubMed ID: 9458106
[TBL] [Abstract][Full Text] [Related]
10. The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells.
Ji Y; Lee HJ; Goodman C; Uskokovic M; Liby K; Sporn M; Suh N
Mol Cancer Ther; 2006 Jun; 5(6):1452-8. PubMed ID: 16818503
[TBL] [Abstract][Full Text] [Related]
11. Effects of chebulinic acid on differentiation of human leukemia K562 cells.
Yi ZC; Wang Z; Li HX; Liu MJ; Wu RC; Wang XH
Acta Pharmacol Sin; 2004 Feb; 25(2):231-8. PubMed ID: 14769215
[TBL] [Abstract][Full Text] [Related]
12. Expression of megakaryocytic and erythroid properties in human leukemic cells.
Tani T; Ylänne J; Virtanen I
Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
[TBL] [Abstract][Full Text] [Related]
13. Resistance of acute myeloid leukemic cells to the triterpenoid CDDO-Imidazolide is associated with low caspase-8 and FADD levels.
Riccioni R; Senese M; Diverio D; Riti V; Mariani G; Boe A; LoCoco F; Foà R; Peschle C; Sporn M; Testa U
Leuk Res; 2008 Aug; 32(8):1244-58. PubMed ID: 18304628
[TBL] [Abstract][Full Text] [Related]
14. A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis.
Liu B; Ohishi K; Yamamura K; Suzuki K; Monma F; Ino K; Nishii K; Masuya M; Sekine T; Heike Y; Takaue Y; Katayama N
Exp Hematol; 2010 Aug; 38(8):685-95. PubMed ID: 20381581
[TBL] [Abstract][Full Text] [Related]
15. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
[TBL] [Abstract][Full Text] [Related]
16. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
[TBL] [Abstract][Full Text] [Related]
17. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S
Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
19. Parallel regulation of PKC-alpha and PKC-delta characterizes the occurrence of erythroid differentiation from human primary hematopoietic progenitors.
Lanuti P; Bertagnolo V; Gaspari AR; Ciccocioppo F; Pierdomenico L; Bascelli A; Sabatino G; Miscia S; Marchisio M
Exp Hematol; 2006 Dec; 34(12):1624-34. PubMed ID: 17157158
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
